- Home
- ANIX vs PFO Comparison
ANIX vs PFO Comparison
Compare ANIX & PFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- PFO
- Stock Information
- Founded
- ANIX 1982
- PFO 1991
- Country
- ANIX United States
- PFO United States
- Employees
- ANIX N/A
- PFO N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- PFO Finance Companies
- Sector
- ANIX Health Care
- PFO Finance
- Exchange
- ANIX Nasdaq
- PFO Nasdaq
- Market Cap
- ANIX 108.9M
- PFO 116.6M
- IPO Year
- ANIX 1987
- PFO N/A
- Fundamental
- Price
- ANIX $3.01
- PFO $9.28
- Analyst Decision
- ANIX Strong Buy
- PFO
- Analyst Count
- ANIX 3
- PFO 0
- Target Price
- ANIX $9.00
- PFO N/A
- AVG Volume (30 Days)
- ANIX 110.3K
- PFO 31.8K
- Earning Date
- ANIX 09-05-2025
- PFO 01-01-0001
- Dividend Yield
- ANIX N/A
- PFO 6.51%
- EPS Growth
- ANIX N/A
- PFO N/A
- EPS
- ANIX N/A
- PFO N/A
- Revenue
- ANIX N/A
- PFO N/A
- Revenue This Year
- ANIX N/A
- PFO N/A
- Revenue Next Year
- ANIX N/A
- PFO N/A
- P/E Ratio
- ANIX N/A
- PFO N/A
- Revenue Growth
- ANIX N/A
- PFO N/A
- 52 Week Low
- ANIX $2.07
- PFO $6.90
- 52 Week High
- ANIX $4.20
- PFO $8.51
- Technical
- Relative Strength Index (RSI)
- ANIX 40.04
- PFO 60.95
- Support Level
- ANIX $3.10
- PFO $9.17
- Resistance Level
- ANIX $3.24
- PFO $9.27
- Average True Range (ATR)
- ANIX 0.16
- PFO 0.05
- MACD
- ANIX -0.04
- PFO -0.00
- Stochastic Oscillator
- ANIX 0.00
- PFO 85.71
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.